Current Radiopharmaceuticals
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.6 | Q2 | 58.1% | 0.394 | Q3 | 52.8% |
| 2024 | 1.2 | Q4 | 24.3% | 0.297 | Q3 | 45.4% |
| 2023 | 1.5 | Q3 | 39.5% | 0.542 | Q2 | 67.5% |
| 2022 | 2.3 | Q3 | 51.8% | 0.379 | Q3 | 57.7% |
| 2021 | 2.0 | Q4 | 47.7% | 0.587 | Q2 | 72.2% |
| 2020 | — | — | 0.586 | Q2 | 71.1% | |
| 2019 | — | — | 0.447 | Q3 | 64.1% | |
| 2018 | — | — | 0.299 | Q3 | 49.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1874-4729
ISSN
1874-4710
country
AEcoverage
2009-2026